Words by Kirstie Turner Climate change is visible all around us and is impacting on people’s health around the world. It is time for the pharmaceutical indus...

Words by Michaila Byrne Amidst the current public discourse surrounding sustainability and ethical practices, is the problem of pharmaceutical waste. From pr...

Words by Isabel O’Brien The Atlantic Ocean divides two English speaking nations, but if these two land masses came together, old coastlines would become hard...

Words by Kirstie Turner Globally, 5 billion people have access to medication, leaving 2 billion, predominantly in the developing world, who do not. As a chal...

Words by Isabel O’Brien What if we told you we could revolutionise your route to work? A brand-new bridge has been built that will get you there for less mon...

Words by Kirstie Turner Pharma is seeing a host of ground-breaking innovations, with companies developing new technologies that are changing patients’ lives ...

Words by James Coker Many of the most transformative innovations are taking place in the developing world on an increasingly regular basis. This article expl...

Words by Louise Rogers China. A nation of meteoric expansion, having quintupled its share of global output in fewer than 40 years. The start of Xi Jinping’s ...

Words by Louise Rogers “Science needs the flow of people and ideas across borders”, read a letter to Teresa May and Jean-Claude Juncker in late 2018, signed ...

Words by Adrian van den Hoven, Director General, Medicines for Europe Europe Now has a Chance to Take on International Competition and Secure the Future of i...

Words by Nick Taylor Developing markets are impossible to ignore. Brazil, Russia, India, and China, collectively known as the BRIC countries, house 40% of th...

Words by Saskia Pronk Environmental and economic sustainability across all sectors is increasingly being thrust under a green-tinted microscope, and the phar...

Brexit Must Not Stop Medicines Reaching the UK Words by Niall Dickson, Co-Chair, Brexit Health Alliance The health system – and indeed British industry, busi...

Words by Martin Lush, Global Vice President, Pharma Biotech and Medical Devices, NSF International. To prosper in this era of brutal disruption with new scie...

Words by Roger Dobson. Ever-rising healthcare costs are resulting in governments and other payers exerting a more profound influence over pharmaceutical mark...